azathioprine has been researched along with Sclerosis, Systemic in 58 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This suggests that treatment of pulmonary fibrosis in SSc with low-dose prednisolone and IV CYC followed by AZA stabilizes lung function in a subset of patients with the disease." | 9.12 | A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. ( Black, CM; Denton, CP; Desai, S; du Bois, RM; Ellis, RW; Emery, P; Foley, NM; Goh, NS; Herrick, AL; Hoyles, RK; Lees, B; McHugh, NJ; Newlands, P; Pearson, SB; Roberts, C; Veale, DJ; Wells, AU; Wellsbury, J, 2006) |
| " This suggests that treatment of pulmonary fibrosis in SSc with low-dose prednisolone and IV CYC followed by AZA stabilizes lung function in a subset of patients with the disease." | 5.12 | A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. ( Black, CM; Denton, CP; Desai, S; du Bois, RM; Ellis, RW; Emery, P; Foley, NM; Goh, NS; Herrick, AL; Hoyles, RK; Lees, B; McHugh, NJ; Newlands, P; Pearson, SB; Roberts, C; Veale, DJ; Wells, AU; Wellsbury, J, 2006) |
| " We report a case of a 70-year-old woman, who was diagnosed with diffuse cutaneous systemic sclerosis and psoriasis vulgaris and was treated with oral azathioprine (50 mg/d) and prednisolone (10 mg/d), topical corticosteroids, and calcipotriols." | 4.31 | Case of systemic sclerosis overlapping with psoriasis. ( Hua, X; Rao, L; Tan, H; Xie, Y; Zhou, P, 2023) |
| "Our patient with SSC-myositis overlap and severe dysphagia requiring PEG feeding, improved with high dose corticosteroids, azathioprine, two courses of IVIG and rituximab, and remained in remission 20 months after hospital discharge." | 3.85 | Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report. ( Chinniah, KJ; Mody, GM, 2017) |
| " Patients were treated with azathioprine and low-dose prednisone if they had progressive pulmonary symptoms (deterioration in the dyspnea score) or poor or deteriorating lung function." | 3.72 | Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. ( Cassim, B; Dheda, K; Lalloo, UG; Mody, GM, 2004) |
| " During first 6 months of the trial, the patients also received prednisolone, which was started at a dosage of 15 mg daily and tapered to zero by the end of the sixth month." | 2.72 | A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. ( Davis, P; Fritzler, M; Kovalenko, W; Nadashkevich, O, 2006) |
| "Azathioprine (AZA) is an immunosuppressant commonly used for organ transplantation and autoimmune diseases." | 2.42 | Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis. ( Hakamada, A; Isoda, K; Kaketa, M; Mizutani, H; Mori, H; Tamada, K; Yamanaka, K; Yamanishi, K, 2004) |
| "European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc's optimal management." | 1.56 | Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort. ( Bertsias, G; Boumpas, D; Bournia, VK; Chatzidionysiou, Κ; Daoussis, D; Dimitroulas, T; Drosos, AA; Garyfallos, Α; Georgiopoulos, G; Liossis, SC; Panopoulos, S; Sakkas, L; Sfikakis, PP; Sidiropoulos, P; Tektonidou, MG; Thomas, K; Vassilopoulos, D; Vosvotekas, G; Voulgari, PV, 2020) |
| "Forty-nine patients affected by systemic sclerosis (44 women and five men, mean age 52." | 1.35 | Cyclophosphamide treatment improves microvessel damage in systemic sclerosis. ( Bambara, LM; Biasi, D; Caramaschi, P; Mahamid, H; Pieropan, S; Tinazzi, I; Volpe, A, 2009) |
| "Primary systemic sclerosis (PSS) is such a disease characterised by multi-organ fibrosis." | 1.35 | Graves' disease associated with primary systemic sclerosis. ( Wimmersberger, Y; Zuercher, D, 2009) |
| " The mean dosage of azathioprin and prednisone in patients with SLE did not significantly differ from the non-SLE group." | 1.27 | [Reactivation of the alpha 1-fetoprotein synthesis in systemic lupus erythematosus]. ( Knopf, B; Schulze, M; Wollina, U, 1985) |
| "A female patient showed signs of osteomyelofibrosis after being treated for 70 months." | 1.26 | [Progressive systemic sclerosis - long-term treatment with azathioprin (author's transl)]. ( Jäckle, B; Maas, D; Raif, W; Schramm, A; Schubothe, H, 1979) |
| "All but one of 28 patients with mixed connective tissue disease (MCTD) who were studied prospectively had arthralgia, and 15 of them had noticed joint swelling." | 1.26 | Articular manifestations of mixed connective tissue disease. ( Alarcón-Segovia, D; Hernández-Ortíz, J; Ramos-Niembro, F, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (44.83) | 18.7374 |
| 1990's | 6 (10.34) | 18.2507 |
| 2000's | 13 (22.41) | 29.6817 |
| 2010's | 8 (13.79) | 24.3611 |
| 2020's | 5 (8.62) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, Y | 1 |
| Hua, X | 1 |
| Tan, H | 1 |
| Rao, L | 1 |
| Zhou, P | 1 |
| Jelovac, M | 1 |
| Kotur, N | 1 |
| Ristivojevic, B | 1 |
| Pavlovic, D | 1 |
| Spasovski, V | 1 |
| Damjanov, N | 1 |
| Pavlovic, S | 1 |
| Zukic, B | 1 |
| Panopoulos, S | 1 |
| Chatzidionysiou, Κ | 1 |
| Tektonidou, MG | 1 |
| Bournia, VK | 1 |
| Drosos, AA | 1 |
| Liossis, SC | 1 |
| Dimitroulas, T | 1 |
| Sakkas, L | 1 |
| Boumpas, D | 1 |
| Voulgari, PV | 1 |
| Daoussis, D | 1 |
| Thomas, K | 1 |
| Georgiopoulos, G | 1 |
| Vosvotekas, G | 1 |
| Garyfallos, Α | 1 |
| Sidiropoulos, P | 1 |
| Bertsias, G | 1 |
| Vassilopoulos, D | 1 |
| Sfikakis, PP | 1 |
| Kiboshi, T | 1 |
| Kotani, T | 1 |
| Konma, J | 1 |
| Makino, H | 1 |
| Matsuda, S | 1 |
| Suzuka, T | 1 |
| Wada, Y | 1 |
| Shiba, H | 1 |
| Hata, K | 1 |
| Shoda, T | 1 |
| Takeuchi, T | 1 |
| Chinniah, KJ | 1 |
| Mody, GM | 2 |
| Zheng, JN | 1 |
| Yang, QR | 1 |
| Zhu, GQ | 1 |
| Pan, L | 1 |
| Xia, JX | 1 |
| Wang, Q | 1 |
| Cappelli, S | 1 |
| Bellando-Randone, S | 1 |
| Guiducci, S | 1 |
| Matucci-Cerinic, M | 1 |
| Poormoghim, H | 1 |
| Rezaei, N | 1 |
| Sheidaie, Z | 1 |
| Almasi, AR | 1 |
| Moradi-Lakeh, M | 1 |
| Almasi, S | 1 |
| Andalib, E | 1 |
| Iudici, M | 1 |
| Cuomo, G | 1 |
| Vettori, S | 1 |
| Bocchino, M | 1 |
| Sanduzzi Zamparelli, A | 1 |
| Cappabianca, S | 1 |
| Valentini, G | 1 |
| Goh, KG | 1 |
| Ong, SG | 1 |
| Robles-Perez, A | 1 |
| Molina-Molina, M | 1 |
| Caramaschi, P | 1 |
| Volpe, A | 1 |
| Pieropan, S | 1 |
| Tinazzi, I | 1 |
| Mahamid, H | 1 |
| Bambara, LM | 1 |
| Biasi, D | 1 |
| Quillinan, NP | 1 |
| Denton, CP | 2 |
| Wimmersberger, Y | 1 |
| Zuercher, D | 1 |
| Bussone, G | 1 |
| Mouthon, L | 2 |
| Chan, PT | 1 |
| Mok, CC | 1 |
| Dheda, K | 1 |
| Lalloo, UG | 1 |
| Cassim, B | 1 |
| Jacobi, AM | 1 |
| Feist, E | 1 |
| Rudolph, B | 1 |
| Burmester, GR | 1 |
| Mori, H | 1 |
| Yamanaka, K | 1 |
| Kaketa, M | 1 |
| Tamada, K | 1 |
| Hakamada, A | 1 |
| Isoda, K | 1 |
| Yamanishi, K | 1 |
| Mizutani, H | 1 |
| Nadashkevich, O | 1 |
| Davis, P | 1 |
| Fritzler, M | 1 |
| Kovalenko, W | 1 |
| Hoyles, RK | 1 |
| Ellis, RW | 1 |
| Wellsbury, J | 1 |
| Lees, B | 1 |
| Newlands, P | 1 |
| Goh, NS | 1 |
| Roberts, C | 1 |
| Desai, S | 1 |
| Herrick, AL | 1 |
| McHugh, NJ | 1 |
| Foley, NM | 1 |
| Pearson, SB | 1 |
| Emery, P | 1 |
| Veale, DJ | 1 |
| Wells, AU | 1 |
| Black, CM | 1 |
| du Bois, RM | 1 |
| Scheja, A | 1 |
| Hesselstrand, R | 1 |
| Wildt, M | 1 |
| Akesson, A | 1 |
| Domysławska, I | 1 |
| Ciołkiewicz, M | 1 |
| Kowal-Bielecka, O | 1 |
| Lewszuk, A | 1 |
| Klimiuk, PA | 1 |
| Sierakowski, S | 1 |
| Bérezné, A | 1 |
| Ranque, B | 1 |
| Valeyre, D | 1 |
| Brauner, M | 1 |
| Allanore, Y | 1 |
| Launay, D | 1 |
| Le Guern, V | 1 |
| Kahn, JE | 1 |
| Couderc, LJ | 1 |
| Constans, J | 1 |
| Cohen, P | 1 |
| Mahr, A | 1 |
| Pagnoux, C | 1 |
| Hachulla, E | 1 |
| Kahan, A | 1 |
| Cabane, J | 1 |
| Guillevin, L | 1 |
| Choy, E | 1 |
| Kingsley, G | 1 |
| Panayi, G | 1 |
| Bottomley, WW | 1 |
| Sheehan-Dare, RA | 1 |
| Hughes, P | 1 |
| Cunliffe, WJ | 1 |
| Komócsi, A | 1 |
| Kumánovics, G | 1 |
| Zibotics, H | 1 |
| Czirják, L | 1 |
| Hellmich, B | 1 |
| Schnabel, A | 1 |
| Bauer, T | 1 |
| Schatz, H | 1 |
| Pirofsky, B | 1 |
| Bardana, EJ | 1 |
| Schulze, P | 1 |
| Alexander, M | 1 |
| Kampf, D | 1 |
| Kurwa, AR | 1 |
| Denman, AM | 1 |
| Maas, D | 1 |
| Schramm, A | 1 |
| Jäckle, B | 1 |
| Raif, W | 1 |
| Schubothe, H | 1 |
| Ramos-Niembro, F | 1 |
| Alarcón-Segovia, D | 1 |
| Hernández-Ortíz, J | 1 |
| Faust, G | 1 |
| Zöller, B | 1 |
| Brinkrolf, H | 1 |
| Yamada, H | 1 |
| Ogawa, H | 1 |
| Sönnichsen, N | 1 |
| Brenke, A | 2 |
| Ruiz, JC | 1 |
| Val, F | 1 |
| de Francisco, AL | 1 |
| de Bonis, E | 1 |
| Zubimendi, JA | 1 |
| Prieto, M | 1 |
| Canga, E | 1 |
| Sanz de Castro, S | 1 |
| Arias, M | 1 |
| Witt, C | 1 |
| Neuhaus, K | 1 |
| Winsel, K | 1 |
| Hiepe, F | 1 |
| Volk, HD | 1 |
| Wollina, U | 1 |
| Schulze, M | 1 |
| Knopf, B | 1 |
| Laaff, H | 1 |
| Balle, C | 1 |
| Schön, S | 1 |
| Freudenberg, N | 1 |
| Schollmeyer, P | 1 |
| Peter, HH | 1 |
| Hällgren, R | 1 |
| Svenson, K | 1 |
| Johansson, E | 1 |
| Lindh, U | 1 |
| Götzel, L | 1 |
| Wüthrich, B | 1 |
| Delespesse, G | 1 |
| Kennes, B | 1 |
| Duchateau, J | 1 |
| Moeschlin, S | 1 |
| Klein, G | 2 |
| Fellner, S | 1 |
| Fellner, R | 1 |
| Skinner, MD | 1 |
| Schwartz, RS | 1 |
| Kerl, H | 1 |
| Sandhofer, M | 1 |
| Saporta, L | 1 |
| Godeau, P | 1 |
| Delrieu, F | 1 |
| Delbarre, F | 1 |
| Rosenthal, DS | 1 |
| Sack, B | 1 |
| Califano, A | 1 |
| Cainelli, T | 1 |
| Ghislanzoni, G | 1 |
| Kostanecki, W | 1 |
| Mazurkiewicz, W | 1 |
| Górkiewicz, A | 1 |
| Zborzil, J | 1 |
| Cruchaud, A | 1 |
| Schuppli, R | 2 |
| Thivolet, J | 1 |
| Perrot, H | 1 |
| Jansen, GT | 1 |
| Barraza, DF | 1 |
| Ballard, JL | 1 |
| Honeycutt, WM | 1 |
| Dillaha, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double Blind Controlled Trial Comparing Rituximab Against Intravenous Cyclophosphamide in Connective Tissue Disease Associated Interstitial Lung Disease[NCT01862926] | Phase 2/Phase 3 | 104 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| A Randomized Controlled Trial to Compare the Efficacy of Oral Mycophenolate Mofetil With Placebo in Patients With Systemic Sclerosis Related Early Interstitial Lung Disease[NCT02896205] | Phase 3 | 41 participants (Actual) | Interventional | 2016-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for azathioprine and Sclerosis, Systemic
| Article | Year |
|---|---|
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Topics: Azathioprine; Biological Products; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; | 2014 |
Treatment Considerations of Lung Involvement in Rheumatologic Disease.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide | 2015 |
Disease-modifying treatment in systemic sclerosis: current status.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Azathioprine; Collagen | 2009 |
Interstitial lung disease in systemic sclerosis.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Contraindications; Cyclophosph | 2011 |
Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Biopsy; Cyclophosphamide | 2012 |
Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis.
Topics: Azathioprine; Diagnosis, Differential; Drug Eruptions; Female; Humans; Immunosuppressive Agents; Lym | 2004 |
Immunosuppressive therapy in rheumatic disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dermatomyositis; Gr | 1977 |
[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Topics: Arthritis, Reactive; Azathioprine; Chronic Disease; Cyclophosphamide; Dermatomyositis; Humans; Immun | 1977 |
[Immunovasculitis-- differential diagnosis and therapy of inflammatory systemic diseases].
Topics: Adult; Angiography; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Diagnosis, Differentia | 1976 |
[Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Arteritis; Autoimmune | 1974 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
5 trials available for azathioprine and Sclerosis, Systemic
| Article | Year |
|---|---|
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive | 2006 |
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Double-Blind Method; | 2006 |
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Double-Blind Method; | 2006 |
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Double-Blind Method; | 2006 |
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Double-Blind Method; | 2006 |
Immunosuppressive therapy in rheumatic disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dermatomyositis; Gr | 1977 |
[Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
Topics: Allopurinol; Arthritis, Rheumatoid; Azathioprine; Blood Cells; Capsules; Clinical Trials as Topic; E | 1972 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
44 other studies available for azathioprine and Sclerosis, Systemic
| Article | Year |
|---|---|
Case of systemic sclerosis overlapping with psoriasis.
Topics: Aged; Azathioprine; Female; Humans; Prednisolone; Psoriasis; Scleroderma, Diffuse; Scleroderma, Syst | 2023 |
Can Pharmacogenetic Variants in
Topics: Azathioprine; Genotype; Humans; Liver-Specific Organic Anion Transporter 1; Methotrexate; Methylenet | 2023 |
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort.
Topics: Adult; Aged; Azathioprine; Cohort Studies; Cyclophosphamide; Endothelin Receptor Antagonists; Female | 2020 |
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis.
Topics: Azathioprine; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Lung Diseases, | 2022 |
Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Deglutition Disorders; Drug Therapy, Combin | 2017 |
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lung | 2020 |
Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female | 2014 |
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Topics: Adult; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 2015 |
Recurrent spontaneous subdural hematoma secondary to immune thrombocytopenia in a patient with overlap syndrome.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Female; Hematoma, Subdural; Humans; Immuno | 2015 |
Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.
Topics: Aged; Azathioprine; Cyclophosphamide; Female; Humans; Immune System; Immunosuppressive Agents; Infla | 2009 |
Graves' disease associated with primary systemic sclerosis.
Topics: Azathioprine; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Graves | 2009 |
Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Female; Glucocor | 2004 |
Sinusoidal dilatation: a rare side effect of azathioprine.
Topics: Azathioprine; Dilatation, Pathologic; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhos | 2004 |
Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis.
Topics: Aged; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; | 2007 |
[Coexistence of scleroderma-like syndrome and idiopathic myelofibrosis in a 54-year-old female patient: case report].
Topics: Antineoplastic Agents; Azathioprine; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive | 2007 |
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Com | 2008 |
Systemic sclerosis occurring in a patient with Adamantiades-Behçet's disease.
Topics: Azathioprine; Behcet Syndrome; Female; Humans; Immunosuppression Therapy; Middle Aged; Scleroderma, | 1993 |
A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents.
Topics: Azathioprine; Chemical Industry; Humans; Male; Middle Aged; Occupational Diseases; Prednisolone; Scl | 1993 |
Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis.
Topics: Adult; Aged; Azathioprine; Bronchoalveolar Lavage Fluid; Dermatomyositis; Drug Therapy, Combination; | 2001 |
[Interstitial pulmonary disease in systemic scleroderma: treatment].
Topics: Azathioprine; Cytokines; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Immunosup | 2002 |
[Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; Derm | 1977 |
Scleroderma treated with immunosuppressive drugs.
Topics: Antilymphocyte Serum; Azathioprine; Female; Humans; Immunosuppressive Agents; Middle Aged; Prednisol | 1979 |
[Progressive systemic sclerosis - long-term treatment with azathioprin (author's transl)].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Azathioprine; Female; Humans; Male; Middle Aged; P | 1979 |
Articular manifestations of mixed connective tissue disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Arthritis, Rheumatoid; Azathioprine; Child; Female; Huma | 1979 |
[Plasma exchange therapy of dermatosis].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Betamethasone; Female; Humans; Middle Aged; Pemphigoid | 1992 |
[Therapeutic possibilities in systemic scleroderma].
Topics: Antibodies, Antinuclear; Autoantibodies; Azathioprine; Combined Modality Therapy; Dose-Response Rela | 1992 |
Progressive systemic sclerosis and renal transplantation: a contraindication to the use of cyclosporine A?
Topics: Azathioprine; Contraindications; Cyclosporins; Drug Therapy, Combination; Female; Humans; Kidney; Ki | 1991 |
[Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].
Topics: Adult; Azathioprine; B-Lymphocyte Subsets; Bronchoalveolar Lavage Fluid; Female; Flow Cytometry; Hum | 1991 |
[Reactivation of the alpha 1-fetoprotein synthesis in systemic lupus erythematosus].
Topics: Alanine Transaminase; alpha-Fetoproteins; Antibodies; Arthritis, Rheumatoid; Aspartate Aminotransfer | 1985 |
[Rapid decrease in renal function (scleroderma renal crisis) in progressive systemic sclerosis treated with immunosuppressive agents].
Topics: Adult; Azathioprine; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Middle Aged; Pr | 1988 |
Abnormal calcium and magnesium stores in erythrocytes and granulocytes from patients with inflammatory connective tissue diseases. Relationship to inflammatory activity and effect of corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Azathioprine; Calcium; Cyclophosphamide; | 1985 |
[Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; | 1973 |
[Treatment of scleroderma].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Antimalarials; Azathioprine; Dextrans; Edetic | 1973 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Disea | 1971 |
[Treatment of "collagen and autoimmune" diseases (author's transl)].
Topics: Adolescent; Adult; Aminobenzoates; Azathioprine; Chloroquine; Cyclophosphamide; Dermatomyositis; Dex | 1973 |
[Generalized scleroderma. Treatment with immunosuppressive agents].
Topics: Adult; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; | 1972 |
Autoimmune hemolytic anemia in scleroderma.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Azathioprine; Clinical Enzyme Tests; Coombs | 1971 |
[1st data on the immunosuppressive therapy of scleroderma].
Topics: Adolescent; Adult; Azathioprine; Child; Female; Humans; Male; Middle Aged; Scleroderma, Systemic | 1971 |
[Hair changes in immunosuppressive therapy].
Topics: Antineoplastic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Hair; Humans; Immunosuppression | 1971 |
[Immunosuppressive treatment of collagen diseases].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Dermatomyosi | 1969 |
[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Topics: Antineoplastic Agents; Azathioprine; Condylomata Acuminata; Fluorouracil; Humans; Immunosuppressive | 1970 |
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Topics: Antineoplastic Agents; Azathioprine; Dermatomyositis; Fluorouracil; Humans; Immunosuppressive Agents | 1970 |
[So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
Topics: Acute Disease; Adult; Azathioprine; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppres | 1970 |
Generalized scleroderma. Treatment with an immunosuppressive agent.
Topics: Adult; Aged; Azathioprine; Blood Sedimentation; Child; Female; Humans; Latex Fixation Tests; Male; M | 1968 |